SHL Telemedicine Shareholders Approve Share Capital Increase

Ticker: SHMLF · Form: 6-K · Filed: Nov 20, 2025 · CIK: 1166834

Shl Telemedicine Ltd 6-K Filing Summary
FieldDetail
CompanyShl Telemedicine Ltd (SHMLF)
Form Type6-K
Filed DateNov 20, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: capital-increase, shareholder-meeting, press-release

TL;DR

SHL Telemedicine shareholders greenlit a share capital increase on Nov 20, 2025.

AI Summary

On November 20, 2025, SHL Telemedicine Ltd. announced that its shareholders approved an increase in the company's share capital. This decision was detailed in a press release issued on the same date, which is incorporated by reference into this SEC filing.

Why It Matters

An increase in share capital can be a precursor to new funding or strategic initiatives, potentially impacting the company's future growth and stock valuation.

Risk Assessment

Risk Level: low — This filing is a routine announcement of a shareholder-approved capital increase, with no immediate negative financial implications presented.

Key Players & Entities

  • SHL Telemedicine Ltd. (company) — Registrant
  • November 20, 2025 (date) — Date of press release and filing

FAQ

What was the primary purpose of the press release issued by SHL Telemedicine Ltd. on November 20, 2025?

The press release, titled 'SHL's shareholders confirm increase of share capital', announced that the company's shareholders confirmed an increase of its share capital.

What is the filing type and date for this report?

This is a Form 6-K report filed as of November 20, 2025.

Where is SHL Telemedicine Ltd. located?

The company's principal executive offices are located at 90 Yigal Alon Street, Tel Aviv, Israel.

Does SHL Telemedicine Ltd. file annual reports under Form 20-F or 40-F?

SHL Telemedicine Ltd. files annual reports under Form 20-F.

What exhibit is incorporated by reference into this filing?

Exhibit 99.1, a press release dated November 20, 2025, titled 'SHL's shareholders confirm increase of share capital', is incorporated by reference.

Filing Stats: 190 words · 1 min read · ~1 pages · Grade level 11.6 · Accepted 2025-11-20 12:00:14

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL TELEMEDICINE LTD. By: /s/ Lior Haalman Lior Haalman Chief Financial Officer November 20, 2025

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.